Updates matching "Access to Biomarker Testing"

State Senator Monique Limón (D-Santa Barbara) introduced legislation to ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence.

Link to video and interview SANTA FE – February 8, 2023 - The American Cancer Society Cancer Action Network (ACS CAN) hosted a ‘Cancer Action Day’ at the state capitol in conjunction with the New Mexico Allied Council on Tobacco (NMACT), today. Joyce Graves,

Rep. Moser’s Legislation Expands Access to Precision Medicine Testing

ATLANTA, GA – January 31, 2023 – Today, Rep. Sharon Cooper filed a bill (HB85) that will allow more Georgians to receive biomarker testing – a routine step in accessing personalized medicine treatments that has become an increasingly important part of cancer care in recent

ALBANY, NY – JANUARY 19, 2023 – Last week the American Cancer Society (ACS) released their annual report “Cancer Facts and Figures” projecting cancer’s impact in 2023. Released in time for Cervical Cancer Awareness Month, the 2023 report estimates that around 850 New Yorkers will be diagnosed with cervical cancer

PHILADELPHIA, PA – JANUARY 18, 2023 – Last week the American Cancer Society (ACS) released their annual report “Cancer Facts and Figures” projecting cancer’s impact in 2023. Released in time for Cervical Cancer Awareness Month, the 2023 report estimates that around 510 Pennsylvanians will be diagnosed with cervical cancer and

OLYMPIA, WA. – As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges state lawmakers to prioritize legislation that ensures biomarker testing is appropriately covered by more insurance plans, including Apple Health, which will ease the burden of cancer on Washington residents.

The following originally appeared in the Albany Times Union on January 9, 2023. In 2022, an estimated 118,830 New Yorkers received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect

Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden